Tenax Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.7% | +23.8% | -26.6% | +839.9% | -3.1% | +15.9% | -5.5% | -2.9% | +1.4% | +18.2% | -1.2% | |
| – | -1.7% | +23.8% | -26.6% | +840.0% | -3.1% | +15.9% | -5.5% | -2.9% | +1.4% | +18.2% | -1.2% | |
| – | -12.1% | +28.2% | -25.2% | +947.6% | -3.5% | +17.5% | -5.4% | -5.8% | -1.8% | +21.7% | -0.7% | |
| – | -12.1% | +28.2% | -25.2% | +947.6% | -3.5% | +17.5% | -5.4% | -5.8% | -1.8% | +21.7% | -0.7% | |
| – | +495.6% | -43.4% | -14.3% | +47.2% | +83.2% | -41.0% | -8.7% | +161.1% | +8.4% | +18.6% | -4.9% | |
| – | +495.6% | -43.4% | -14.3% | +47.2% | +83.2% | -41.0% | -8.7% | +161.1% | +8.4% | +18.6% | -4.9% | |
| – | +187.1% | -17.5% | -32.5% | – | – | – | – | – | – | – | – | |
| – | +1,438.1% | -47.9% | -19.5% | +82.2% | +99.3% | -41.7% | -69.4% | +897.9% | +7.7% | +5.0% | +7.1% | |
| – | -28.3% | +53.5% | -28.6% | +995.3% | -5.4% | +18.8% | -5.5% | -6.9% | +0.9% | +18.2% | -1.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -16.7% | +390.7% | +60.6% | +980.6% | -27.8% | +139.6% | +8.2% | +0.4% | -1.3% | +15.3% | +12.5% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.